FierceBiotechOriginal article
{"a":[{"_":"IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy","$":{"href":"/medtech/ihealthscreen-garners-fda-nod-ai-backed-dx-spot-mild-diabetic-retinopathy","hreflang":"en"}}]}
RegulatoryapprovedIHealthScreen AI-powered diagnosticPositive
AI Analysis
Summary
IHealthScreen received FDA 510(k) clearance for its AI-powered diagnostic tool that detects mild diabetic retinopathy in previously undiagnosed diabetic adults. This represents regulatory approval for the company's artificial intelligence-based medical device.
Outcome Details
FDA 510(k) clearance granted
Importance:6/10
Sentiment:
0.80
FDA clearance510(k)AI diagnosticsdiabetic retinopathyundiagnosed patients
Read the original article
Published by FierceBiotech on July 10, 2026 8:58 AM